Compare · BDMD vs MDLN
BDMD vs MDLN
Side-by-side comparison of Baird Medical Investment Holdings Ltd (BDMD) and Medline Inc. (MDLN): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both BDMD and MDLN operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
- MDLN is the larger of the two at $48.08B, about 1893.5x BDMD ($25.4M).
- MDLN has been more active in the news (7 items in the past 4 weeks vs 5 for BDMD).
- MDLN has more recent analyst coverage (25 ratings vs 0 for BDMD).
- Company
- Baird Medical Investment Holdings Ltd
- Medline Inc.
- Price
- -
- -
- Market cap
- $25.4M
- $48.08B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Medical/Dental Instruments
- Medical/Dental Instruments
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2025
- News (4w)
- 5
- 7
- Recent ratings
- 0
- 25
Latest BDMD
- Baird Medical Highlights Global Expansion and Strategic Progress During Third Quarter 2026
- SEC Form SCHEDULE 13G filed by Baird Medical Investment Holdings Ltd
- SEC Form 6-K filed by Baird Medical Investment Holdings Ltd
- SEC Form 6-K filed by Baird Medical Investment Holdings Ltd
- SEC Form 424B5 filed by Baird Medical Investment Holdings Ltd
- Baird Medical to Present at the H.C. Wainwright 28th Annual Global Investment Conference
- Baird Medical Highlights Participation at CIRSE 2026 and Showcases Microwave Ablation Technology
- SEC Form 6-K filed by Baird Medical Investment Holdings Ltd
- Baird Medical Reports 25% Revenue Growth and Positive Net Income for Six Months Ended June 30, 2026
- Baird Medical Expands Global Microwave Ablation Footprint with Additional Product Registrations in Pakistan
Latest MDLN
- SEC Form 8-K filed by Medline Inc.
- Medline to build Midwestern network with new 800,000-square-foot facility in Van Buren Township, Mich.
- SEC Form 4 filed by Medline Inc.
- Medline launches enhanced TrackPoint™ to simplify inventory management for post-acute care
- SEC Form 4 filed by Medline Inc.
- MEDLINE INC. MDLN INVESTORS: Contact Kirby McInerney LLP About the Firm’s Securities Investigation Following 12.8% Share Drop
- Medline to report third quarter 2026 results on November 4, 2026
- INVESTOR ACTION NOTICE: Moore Law PLLC Encourages Investors in Medline Inc. to Contact Law Firm
- Medline announces participation in the Morgan Stanley 24th Annual Global Healthcare Conference
- SEC Form 4 filed by Chief Executive Officer Boyle James M